Drug Retail(BK4128),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4128 Drug Retail

Closed 03-03 16:00:00 EST

66.26

-2.48

-3.61%

High68.22	Low65.82	Vol14.78M
Open68.22	D1 Closing68.74	Amplitude3.50%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O2.36M	T/O Rate--	Tradable Shares0.00
P/B-2.219167	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4128","market":"US","secType":"PLATE","nameCN":"Drug Retail","latestPrice":66.256516,"timestamp":1772571599999,"preClose":68.73583,"halted":0,"volume":14779171,"delay":0,"changeRate":-0.03607,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-2.479317,"latestTime":"03-03 16:00:00 EST","open":68.22454,"high":68.22454,"low":65.81779,"amount":2364173.528485,"amplitude":0.035015,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1772586000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":-2.219167,"peRate":-2.059685,"turnoverRate":0.0497,"increases":1,"decrements":3,"flats":0,"marketCap":139160928,"floatMarketCap":77930008.5},"requestUrl":"/m/hq/s/BK4128/tweets","defaultTab":"tweets","newsList":[{"id":"2616323663","title":"SRX Health Solutions Announces Series B Preferred Stock Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2616323663","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616323663?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:38","pubTimestamp":1772545101,"startTime":"0","endTime":"0","summary":"SRX Health Solutions Inc. said it plans a new private placement in which it would sell shares of a newly created Series B convertible preferred stock and related warrants to accredited investors in one or more closings. The company also disclosed that certain existing investors have signed waivers allowing the offering and giving up participation rights, and consented to the Series B preferred stock ranking pari passu with the company’s Series A preferred stock for liquidation and dividend preferences.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SRX Health Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL7X0Rsf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","SRXH","BK4128"],"gpt_icon":0},{"id":"2616948358","title":"Arqit and RAD announce Quantum-Safe collaboration Against Evolving Cyberthreats","url":"https://stock-news.laohu8.com/highlight/detail?id=2616948358","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616948358?lang=en_us&edition=fundamental","pubTime":"2026-03-02 22:00","pubTimestamp":1772460000,"startTime":"0","endTime":"0","summary":"LONDON, March  02, 2026  (GLOBE NEWSWIRE) -- Arqit (Nasdaq: ARQQ, ARQQW), a global leader in PQC migration tooling and quantum-safe encryption, and RAD, a global leader in networking edge solutions, t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/02/3247489/0/en/Arqit-and-RAD-announce-Quantum-Safe-collaboration-Against-Evolving-Cyberthreats.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0054578231.USD","HNDL","RAD","DCI","BK4161","BK4128"],"gpt_icon":0},{"id":"2613719398","title":"Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613719398","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613719398?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:30","pubTimestamp":1771936200,"startTime":"0","endTime":"0","summary":"First radiotherapeutic agent developed by Radiopharm Ventures, the joint venture between Radiopharm Theranostics and MD Anderson Cancer Center Preclinical animal studies of BetaBart (RV-01) have demon","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3243439/0/en/Radiopharm-Theranostics-Doses-First-Patient-in-Phase-1-2a-Clinical-Study-of-BetaBart-RV-01.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RADX","BK4128","RAD","BK4139"],"gpt_icon":0},{"id":"2613926737","title":"Mangoceuticals Says MGX-0024 Cuts H5N1 Deaths and Eliminates Respiratory Mortality in Poultry Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2613926737","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613926737?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:05","pubTimestamp":1771880723,"startTime":"0","endTime":"0","summary":"Mangoceuticals Inc. reported new data on its antiviral compound MGX-0024 from three commercial poultry field trials in Tamil Nadu, India, involving about 29,000 broiler chickens given MGX-0024 in drinking water from around day 14 through market age. The company said no mortality in treated flocks was attributed to respiratory pathogens, with minimal deaths attributed mainly to heat stress; diagnostic confirmation relied on clinical observation and farm records, and PCR/serology testing was not uniformly applied. Mangoceuticals also cited a completed controlled H5N1 challenge study conducted at ICAR-NIHSAD under BSL-3 conditions , where a 48-hour pre-treatment group showed reduced mortality versus controls and extended mean time to death, with intermittent low-level viral shedding in survivors. The company stated these results have already been issued in a late-2025 technical report and a final signed NIHSAD report and announced plans for additional multi-farm studies.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL4ckjbt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","MGRX","IE00BKPKM429.USD","BK4585","BK4588","IE00B64PRP62.GBP","LU2210149790.SGD","LU2210150020.SGD","LU0314104364.USD","SG9999014013.SGD","SG9999014039.USD","BK4128","IE00B3QW5Z07.USD","LU2095319765.USD","BK4112","SG9999014021.USD","SG9999014005.SGD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2613737737","title":"Mangoceuticals Inc - Mortality Reduced by up to 60% in Pre-Treatment Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2613737737","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613737737?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:05","pubTimestamp":1771880700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nTUA8SLPK7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4128","MGRX"],"gpt_icon":0},{"id":"2613473016","title":"Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2613473016","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613473016?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:05","pubTimestamp":1771880700,"startTime":"0","endTime":"0","summary":"Dallas, TX, Feb.  23, 2026  (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure tele","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/23/3243022/0/en/Mangoceuticals-Patented-MGX-0024-Achieves-Zero-Respiratory-Related-Mortality-in-29-000-Bird-Field-Trials-and-Demonstrates-Prophylactic-Benefit-Against-H5N1-in-Controlled-Government.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4128","MGX","BK4139","HPAI","MGRX"],"gpt_icon":0},{"id":"2613733343","title":"Asian Equities Traded in the US as American Depositary Receipts Start Week Slightly Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2613733343","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613733343?lang=en_us&edition=fundamental","pubTime":"2026-02-23 23:35","pubTimestamp":1771860957,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts opened the week modestly higher Monday morning, rising 0.10% to 2,989.81 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by electric vehicle maker NIO  and thin-film liquid display maker LG Display , which advanced 5.7% and 3.6%, respectively. They were followed by online game developer The9  and healthcare platform 111 , which increased 3.5% and 2.7,% respectively.The decliners from North Asia were led by automotive marketplace Cango  and computer hardware Canaan , which dropped 7% and 5.5,% respectively. They were followed by fintech firm Jiayin Group  and travel company Tuniu , which lost 2.7% and 1.6% respectively.From South Asia, the gainers were led by telecommunications operators Telekomunikasi Indonesia  and PLDT , which rose 1.6% each. They were followed by pharmaceutical company Dr. Reddy's Laboratories  and lender HDFC Bank , which were up 1.2% and 0.7%, respectively.The decliners from South A","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999014013.SGD","LU1791710582.SGD","LU0516423174.USD","SG9999014484.SGD","LU2226246903.HKD","BK7096","BK4505","BK4555","LU1242518931.SGD","LU0197773160.USD","LU1770036033.HKD","LU0499858602.USD","LU0572939691.SGD","SG9999013486.USD","LU0630378692.HKD","BK4128","BK4122","LU0066902890.USD","LU0456842615.SGD","LU0431992006.USD","LU0231203729.USD","BK4600","IE0034224299.USD","LU1267930656.SGD","LU0197773673.USD","BK4551","LU1805238398.USD","BK4089","LU2663582299.SGD","SIFY","LU0531971678.HKD","LU0797268264.HKD","IE00B7N09G41.SGD","PHI","SG9999001135.SGD","LU0210637038.USD","IE00B3M56506.USD","LU2125910500.SGD","LU0831103253.SGD","BK4595","SG9999014005.SGD","BK4596","RDY","NIO","LU0890818403.SGD","BK4148","LU0516423091.SGD","BK4214","IE00B0JY6M65.USD","BK4115","LU0499858438.USD","LU2265009873.SGD","BK4132","LU2177674079.SGD","BK4518","LU0333810181.USD","LU1861220207.SGD","BK4170","LU0979878070.USD","SG9999002406.SGD","LU0589944569.HKD","LU2279701549.SGD","LU1323998911.USD","LU0516422366.SGD","LU0516422952.EUR","CANG","LU0164881194.USD","BK4585","LU0630378429.USD","LU1102505762.USD","BK4107","LU0572940350.SGD","LU0345776255.USD","LU1242518857.USD","LU0348814723.USD","BK4207","BK4166","SG9999014492.USD","BK4581","LU0823038988.USD","BK7508","LU2065169927.USD","SG9999013478.USD","IE0001KFT4U8.USD","09866","BK4534","LU0528227936.USD","SG9999002679.SGD","LU0918141705.HKD","BK4554","SGXZ58947870.SGD","IE00BD6J9T35.USD","LU0791590937.USD","LU0791591158.USD","WIT","SE","BK4588","LU0532188223.SGD","LU1804176565.USD","TLK","NIOG","BK4509","BK4117","JFIN","LU0261945553.USD","BK4220","LU1791710400.SGD","LU0541502299.USD","TOUR","BK7502","INFY","SG9999002604.SGD","BK4526","LU2152927971.USD","LU0868486357.SGD","LU1861217088.USD","LU2360107671.USD","LU0441851309.USD","LU0048573645.USD","LU0320764599.SGD","BK4085","LU0536402901.SGD","SG9999005177.SGD","YI","LU0862451753.SGD","LU1282648689.USD","LU2065171402.SGD","NCTY","LPL","LU0197229882.USD","LU2238330802.EUR","IE0031814969.USD","LU0737861269.HKD","BK4548","BK7016","BK4007","EVS.SI","BK4532","LU2543165471.USD","LU0251143029.SGD","LU0348788117.USD","BK4533","LU1854104046.USD","BK4023","SG9999004360.SGD","BK4535","LU0307460401.USD","LU1105468828.SGD","LU2065171311.SGD","NIO.SI","SG9999002620.SGD","BK4577","IE00BYTNYM70.SGD","LU0264606111.USD","BK4134","LU2008162690.USD","LU0287143357.SGD","BK4566","LU0823039010.USD","HDB","LU2087589342.USD","SG9999014021.USD","LU0918141887.USD","LU0072462343.USD","LU0390134368.USD","BK4574","LU1839390173.USD","BK4531","LU0052750758.USD","LU0175139822.USD","LU1854103824.USD","LU0898667661.SGD","LU2125910849.SGD","BK4099","LU1048588211.SGD","BK4504","SG9999002414.USD","LU0541501648.USD","LU2065170008.USD","SG9999013460.SGD","SG9999006266.SGD","LU1366334651.USD","BK4523","BK4557","LU0708995583.HKD","LU0348816934.USD","LU0348744763.USD","LU1366334578.USD","LU0345775950.USD","BK4503","LU0289960550.SGD","CAN","SG9999014039.USD","BK4142","LU0708995666.HKD","LU1508157978.USD","LU0516422440.USD","LU2045819591.USD"],"gpt_icon":1},{"id":"2612260198","title":"Mangoceuticals Shares Rise 81% on Strong Sales of Injectable Testosterone Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2612260198","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612260198?lang=en_us&edition=fundamental","pubTime":"2026-02-20 22:30","pubTimestamp":1771597837,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nFWN3ZG0S5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2612646260","title":"Here’s Why Mangoceuticals Stock (MGRX) Rocketed Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2612646260","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612646260?lang=en_us&edition=fundamental","pubTime":"2026-02-20 22:09","pubTimestamp":1771596568,"startTime":"0","endTime":"0","summary":"Mangoceuticals stock saw strong momentum today alongside positive results from its TRT program.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/heres-why-mangoceuticals-stock-mgrx-rocketed-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/heres-why-mangoceuticals-stock-mgrx-rocketed-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2612267253","title":"Srx Health Solutions Increases Ownership of Opendoor Technologies by 30% and Is NOW Net Long Cryptocurrency Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2612267253","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612267253?lang=en_us&edition=fundamental","pubTime":"2026-02-20 22:01","pubTimestamp":1771596091,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nFWN3ZG0XI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4212","SRXH","BK4128"],"gpt_icon":0},{"id":"2612267444","title":"SRx Health Solutions Raises Opendoor Stake by 30% and Turns Net Long Crypto Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2612267444","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612267444?lang=en_us&edition=fundamental","pubTime":"2026-02-20 22:00","pubTimestamp":1771596050,"startTime":"0","endTime":"0","summary":"SRx Health Solutions Inc. said it increased its ownership in the common stock of Opendoor Technologies Inc. by 30%. The company also said it further reduced its short position across its Bitcoin and Ethereum cryptocurrency portfolio and is now net long its cryptocurrency holdings.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDLbdTTB2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014021.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","BK4112","BK4585","LU2210150020.SGD","BK4128","OPEG","OPEX","SG9999014013.SGD","OPEN","BK4562","IE00BKPKM429.USD","SG9999014039.USD","LU2095319765.USD","IE00BGHQF748.EUR","LU2210149790.SGD","SRXH","BK4079","BK4561","BK4212","LU0314104364.USD","SG9999014005.SGD"],"gpt_icon":1},{"id":"2612264041","title":"NYSE American issues warning letter to SRx Health Solutions for listing and shareholder approval violations","url":"https://stock-news.laohu8.com/highlight/detail?id=2612264041","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612264041?lang=en_us&edition=fundamental","pubTime":"2026-02-20 21:00","pubTimestamp":1771592409,"startTime":"0","endTime":"0","summary":"SRx Health Solutions said it received a public warning letter from NYSE American alleging it violated exchange rules by issuing about 7.5 million common shares upon conversion of Series A preferred stock without first obtaining required NYSE listing approval and with stockholder approval the exchange deemed deficient under its internal guidance. The company said it had sought listing approval and had obtained stockholder consent, and noted the preferred shares have since been fully converted or redeemed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SRX Health Solutions Inc. published the original content used to generate this news brief via GlobeNewswire  on February 20, 2026, and is solely responsible for the information contained t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL4NYzF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SRXH","IE00BKPKM429.USD","LU2210149790.SGD","BK4128","IE00BGHQF748.EUR","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014021.USD","LU2095319765.USD","SG9999014005.SGD","BK4585","SG9999014013.SGD","BK4212","BK4112","LU2210150020.SGD","LU0314104364.USD","BK4588","SG9999014039.USD"],"gpt_icon":0},{"id":"2612264016","title":"Srx Health Solutions Announces Receipt of Warning Letter From Nyse American","url":"https://stock-news.laohu8.com/highlight/detail?id=2612264016","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612264016?lang=en_us&edition=fundamental","pubTime":"2026-02-20 21:00","pubTimestamp":1771592401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nTUA5KPW34:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4128","SRXH","BK4212"],"gpt_icon":0},{"id":"2612492269","title":"AITX Expands RAD RIO Mini Deployments With Repeat Order","url":"https://stock-news.laohu8.com/highlight/detail?id=2612492269","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612492269?lang=en_us&edition=fundamental","pubTime":"2026-02-20 19:33","pubTimestamp":1771587209,"startTime":"0","endTime":"0","summary":"Artificial Intelligence Technology Solutions ( ($AITX) ) just unveiled an update. On February 20, 2026, AITX announced that its subsidiary RAD rece...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aitx-expands-rad-rio-mini-deployments-with-repeat-order?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aitx-expands-rad-rio-mini-deployments-with-repeat-order?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AITX","BK4168","BK4128","BK4585","RIO","RAD","BK4588"],"gpt_icon":0},{"id":"2612126658","title":"BUZZ-Mangoceuticals surges on strong sales of injectable testosterone therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2612126658","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612126658?lang=en_us&edition=fundamental","pubTime":"2026-02-20 18:54","pubTimestamp":1771584882,"startTime":"0","endTime":"0","summary":"BUZZ-Mangoceuticals surges on strong sales of injectable testosterone therapy ** Shares of telehealth platform Mangoceuticals MGRX.O rise 43% to 51 cents premarket** Co says its new $99/month injectable testosterone therapy plan saw sales jump 336% monthovermonth since midDecember** MGRX says it also cut its customer acquisition costs by more than half** Mangoceuticals expects testosterone therapy to become its main growth driver** In 2025, MGRX plunged 70%  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nL4N3ZG0KA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2612536231","title":"MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2612536231","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612536231?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:05","pubTimestamp":1771535100,"startTime":"0","endTime":"0","summary":"Month over Month Growth of 336% and 54% Reduction in Customer Acquisition Cost (CAC) DALLAS, TX, Feb.  19, 2026  (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (the “Company” or “MangoRx”), a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/19/3241540/0/en/MangoRx-Experiences-Initial-Success-with-Newly-Launched-99-month-All-Inclusive-Injectable-Testosterone-Replacement-Therapy-TRT-Treatment-Program.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","BK4211","BK4147","TRT","MGRX","BK4159","CAGR","CAC"],"gpt_icon":0},{"id":"2612286234","title":"Guardian Pharmacy Services Hosts Annual Sales and Account Management Meeting in Atlanta","url":"https://stock-news.laohu8.com/highlight/detail?id=2612286234","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612286234?lang=en_us&edition=fundamental","pubTime":"2026-02-19 23:44","pubTimestamp":1771515858,"startTime":"0","endTime":"0","summary":"Guardian Pharmacy Services Inc. hosted its annual Sales & Account Management Meeting in Atlanta, bringing together nearly 300 employees from across the country. The event aligned sales, account management, and pharmacy leadership around key priorities, with sessions themed “Racing Towards Success” focused on best practices, team coordination, service delivery, and improving the customer experience.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardian Pharmacy Services Inc. published the original content used to generate this news brief on February 19, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL9xDCll:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","BK4196","GRDN"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0081},{"period":"3month","weight":0.0071},{"period":"6month","weight":0.0662},{"period":"1year","weight":0.1552},{"period":"ytd","weight":0.0065}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4128","nameEN":"BK4128"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Drug Retail(BK4128),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Drug Retail(BK4128) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Drug Retail,BK4128,Drug Retail股票,Drug Retail股票老虎,Drug Retail股票老虎国际,Drug Retail行情,Drug Retail股票行情,Drug Retail股价,Drug Retail股市,Drug Retail股票价格,Drug Retail股票交易,Drug Retail股票购买,Drug Retail股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Drug Retail(BK4128),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Drug Retail(BK4128) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction